NASDAQ : TRVI

Trevi Therapeutics, Inc.

$18.145 USD

$0.23 (1.31%)

Volume
1.91M
Average Volume
2.02M
Market Capitalization
$2.58B
P/E Ratio
-56.32
Dividend Yield
0.00%
Price Target
$25.00
Year High
$20.15
Year Low
$6.55
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$24.75

TRVI Estimated and Actual Revenue by Quarter

TRVI Estimated and Actual EPS by Quarter

TRVI Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 - - - - - -
2028-09-30 1 - - - - - -
2028-06-30 1 - - - - - -
2028-03-31 1 - - - - - -
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 39.03M 39.03M 39.03M - - -
2028-09-30 1 37.58M 37.58M 37.58M - - -
2028-06-30 1 37.59M 37.59M 37.59M - - -
2028-03-31 1 36.79M 36.79M 36.79M - - -
2027-12-31 0 -29.85M -29.85M -29.85M - - -
2027-09-30 0 -27.66M -27.66M -27.66M - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 67.56M 67.56M 67.56M 5 0.2681 0.2681 0.2681
2028-09-30 1 63.74M 63.74M 63.74M 5 0.2581 0.2581 0.2581
2028-06-30 1 62.46M 62.46M 62.46M 6 0.2582 0.2582 0.2582
2028-03-31 1 61.19M 61.19M 61.19M 3 0.2527 0.2527 0.2527
2027-12-31 0 - - - 2 -0.205 -0.205 -0.205
2027-09-30 0 - - - 2 -0.19 -0.19 -0.19